William Blair initiated coverage of Ocular Therapeutix (OCUL) with an Outperform rating.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OCUL:
- Buy Recommendation for Ocular Therapeutix: Axpaxli’s Potential to Revolutionize nAMD Treatment
- Ocular Therapeutix added to Analyst Current Favorites list at Raymond James
- Ocular Therapeutix initiated with an Outperform at RBC Capital
- Beam, Unity, Checkpoint, Inuvo, Ocular: Trending by Analysts
- Biotech Alert: Searches spiking for these stocks today